8月24日,瑛泰医疗(01501)发布中期业绩公告,截至2026年6月30日止六个月期间,公司的收入约为5.96亿元,较截至2025年6月30日止六个月期间的约4.61亿元增加约29.28%。收入增加主要是由于收购及并购填补了产品缺口,构建了完整的产品品类矩阵,以及通过渠道复用及供应链整合实现协同效应,从而推动介入医疗器械销量增长。 报告期内,销售介入医疗器械产生的收入约为5.34亿元,较截至...
Source Link8月24日,瑛泰医疗(01501)发布中期业绩公告,截至2026年6月30日止六个月期间,公司的收入约为5.96亿元,较截至2025年6月30日止六个月期间的约4.61亿元增加约29.28%。收入增加主要是由于收购及并购填补了产品缺口,构建了完整的产品品类矩阵,以及通过渠道复用及供应链整合实现协同效应,从而推动介入医疗器械销量增长。 报告期内,销售介入医疗器械产生的收入约为5.34亿元,较截至...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.